0.55Open0.55Pre Close0 Volume9 Open Interest16.00Strike Price0.00Turnover9179.18%IV13.54%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.55Extrinsic Value100Contract SizeAmericanOptions Type-0.2554Delta0.0987Gamma32.49Leverage Ratio-365.2353Theta0.0000Rho-8.30Eff Leverage0.0001Vega
Summit Therapeutics Stock Discussion
$Nxu Inc (NXU.US)$ grab some on your way out.
After the dual-antibody drug data from Summit Therapeutics (SMMT.US) defeated the "drug king", it was listed as Citigroup's preferred stock and the target price was raised.
No comment yet